The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/20790
StudyName: Eligibility Essential Hypertension NCT00343551
Date of export from the portal: 02.07.2020
Date of Upload / last change: 17.03.2017
License: Creative Commons BY 4.0

----

Description: 
Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.; ODM derived from: https://clinicaltrials.gov/show/NCT00343551
